Evidence map›Paper›PMID 30835739›Full record

ArticlePloS one2019

HCV transmission in high-risk communities in Bulgaria.

Lilia Ganova-Raeva, Zoya Dimitrova, Ivailo Alexiev, Lili Punkova, Amanda Sue, Guo-Liang Xia, Anna Gancheva, Reneta Dimitrova, Asya Kostadinova, Elitsa Golkocheva-Markova and 1 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Widespread hepatitis C virus transmission network among people who inject drugs in Kenya.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lilia Ganova-RaevaCenters for Disease Control and Prevention, Division of Viral Hepatitis, Molecular Epidemiology and Bioinformatics, Atlanta, GA, United States of Ameirca.ORCID 0000-0001-6698-256X
Zoya DimitrovaCenters for Disease Control and Prevention, Division of Viral Hepatitis, Molecular Epidemiology and Bioinformatics, Atlanta, GA, United States of Ameirca.
Ivailo AlexievNational Reference Confirmatory Laboratory for HIV, National Center for Infectious and Parasitic Diseases, Sofia, Bulgaria.
Lili PunkovaCenters for Disease Control and Prevention, Division of Viral Hepatitis, Molecular Epidemiology and Bioinformatics, Atlanta, GA, United States of Ameirca.
Amanda SueCenters for Disease Control and Prevention, Division of Viral Hepatitis, Molecular Epidemiology and Bioinformatics, Atlanta, GA, United States of Ameirca.
Guo-Liang XiaCenters for Disease Control and Prevention, Division of Viral Hepatitis, Molecular Epidemiology and Bioinformatics, Atlanta, GA, United States of Ameirca.
Anna GanchevaNational Reference Confirmatory Laboratory for HIV, National Center for Infectious and Parasitic Diseases, Sofia, Bulgaria.
Reneta DimitrovaNational Reference Confirmatory Laboratory for HIV, National Center for Infectious and Parasitic Diseases, Sofia, Bulgaria.ORCID 0000-0001-7711-6798
Asya KostadinovaNational Reference Confirmatory Laboratory for HIV, National Center for Infectious and Parasitic Diseases, Sofia, Bulgaria.
Elitsa Golkocheva-MarkovaNational Reference Laboratory of Hepatitis, National Center for Infectious and Parasitic Diseases, Sofia, Bulgaria.
Yury KhudyakovCenters for Disease Control and Prevention, Division of Viral Hepatitis, Molecular Epidemiology and Bioinformatics, Atlanta, GA, United States of Ameirca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rate of HIV infection in Bulgaria is low. However, the rate of HCV-HIV-coinfection and HCV infection is high, especially among high-risk communities. The molecular epidemiology of those infections has not been studied before.

methodsConsensus Sanger sequences of HVR1 and NS5B from 125 cases of HIV/HCV coinfections, collected during 2010-2014 in 15 different Bulgarian cities, were used for preliminary phylogenetic evaluation. Next-generation sequencing (NGS) data of the hypervariable region 1 (HVR1) analyzed via the Global Hepatitis Outbreak and Surveillance Technology (GHOST) were used to evaluate genetic heterogeneity and possible transmission linkages. Links between pairs that were below and above the established genetic distance threshold, indicative of transmission, were further examined by generating k-step networks.

resultsPreliminary genetic analyses showed predominance of HCV genotype 1a (54%), followed by 1b (20.8%), 2a (1.4%), 3a (22.3%) and 4a (1.4%), indicating ongoing transmission of many HCV strains of different genotypes. NGS of HVR1 from 72 cases showed significant genetic heterogeneity of intra-host HCV populations, with 5 cases being infected with 2 different genotypes or subtypes and 6 cases being infected with 2 strains of same subtype. GHOST revealed 8 transmission clusters involving 30 cases (41.7%), indicating a high rate of transmission. Four transmission clusters were found in Sofia, three in Plovdiv, and one in Peshtera. The main risk factor for the clusters was injection drug use. Close genetic proximity among HCV strains from the 3 Sofia clusters, and between HCV strains from Peshtera and one of the two Plovdiv clusters confirms a long and extensive transmission history of these strains in Bulgaria.

conclusionsIdentification of several HCV genotypes and many HCV strains suggests a frequent introduction of HCV to the studied high-risk communities. GHOST detected a broad transmission network, which sustains circulation of several HCV strains since their early introduction in the 3 cities. This is the first report on the molecular epidemiology of HIV/HCV coinfections in Bulgaria.

Indexed as

AdultBulgariaCoinfectionDisease OutbreaksFemaleGenotypeHepacivirusHepatitis CHigh-Throughput Nucleotide SequencingHIV InfectionsHumansMaleMolecular EpidemiologyPhylogenyRisk FactorsSexual and Gender Minorities

Identifiers

PMID30835739
PMCPMC6400337

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.